Pomalidomide in Relapsed and Refractory Multiple Myeloma (RRMM)

NCT02406222 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

124

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Pomalidomide
DRUG: Dexamethasone
DRUG: Cyclophosphamide

Sponsor

University of Leeds

Collaborators

[object Object]
[object Object]